Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Sections
Personal tools
Log in
You are here: Home Biomarkers TNFAIP1

TNFAIP1

Basics

Aliases:
This biomarker is also known as:
  • MGC2317,
  • BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation,
  • Protein B12,
  • tumor necrosis factor, alpha-induced protein 1,
  • B12,
  • Q13829,
  • Tumor necrosis factor, alpha-induced protein 1, endothelial,
  • BTB/POZ domain-containing protein TNFAIP1,
  • hBACURD2,
  • protein 2,
  • B61,
  • OTTHUMP00000163324,
  • BACURD2,
  • EDP1,

Description…

The expression of this gene can be induced by the tumor necrosis factor alpha (TNF) in umbilical vein endothelial cells. Mouse studies suggest the expression of this gene is developmentally regulated in a tissue-specific manner. Thought to be involved in regulation of cytoskeleton structure.

Attributes

QA State: Under Review
Type: Protein
Short Name:

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.